The small molecule phenamil is a modulator of adipocyte differentiation and PPARγ expression

Kye Won Park, Hironori Waki, Sung-Pil Choi, Ki‐Moon Park, Peter Tontonoz

Journal of Lipid Research · 2010 · 47 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

We previously described the use of a cell-based screening approach to identify small molecules that regulate adipocyte differentiation. Here we identify the amiloride derivative phenamil as an adipogenic compound. Phenamil acutely induces expression of the key transcription factor of adipogenesis, peroxisome proliferator-activated receptor γ (PPARγ) and, consequently, promotes the differentiation of multiple preadipocyte cell lines, including 3T3-L1 and F442A. Interestingly, the adipogenic action of phenamil is distinct from and additive with both PPARγ ligands and the previously identified adipogenic small molecule harmine. To identify signaling pathways mediating phenamil's effects, we performed transcriptional profiling of 3T3-F442A preadipocytes. ETS variant 4 (ETV4) was identified as a gene rapidly phenamil adipogenic small molecules PPARγ expression of the expression of of promotes expression of PPARγ and and differentiation. of PPARγ expression the of phenamil adipocyte differentiation and gene phenamil of that of PPARγ differentiation identify a phenamil as small molecule the of adipocyte differentiation that of We previously described the use of a cell-based screening approach to identify small molecules that regulate adipocyte differentiation. Here we identify the amiloride derivative phenamil as an adipogenic compound. Phenamil acutely induces expression of the key transcription factor of adipogenesis, peroxisome proliferator-activated receptor γ (PPARγ) and, consequently, promotes the differentiation of multiple preadipocyte cell lines, including 3T3-L1 and F442A. Interestingly, the adipogenic action of phenamil is distinct from and additive with both PPARγ ligands and the previously identified adipogenic small molecule harmine. To identify signaling pathways mediating phenamil's effects, we performed transcriptional profiling of 3T3-F442A preadipocytes. ETS variant 4 (ETV4) was identified as a gene rapidly phenamil adipogenic small molecules PPARγ expression of the expression of of promotes expression of PPARγ and and differentiation. of PPARγ expression the of phenamil adipocyte differentiation and gene phenamil of that of PPARγ differentiation identify a phenamil as small molecule the of adipocyte differentiation that of proliferator-activated receptor γ (PPARγ) is a of the receptor that as the transcriptional of of a transcription PPARγ with receptor and adipogenic gene PPARγ a of and as and transcriptional pathways that expression of PPARγ to that to PPARγ expression and expression of induces and of transcription transcription factor is a key of adipocyte of factor transcriptional of and factor peroxisome expression and and of transcription factor a of with to and factor transcription regulate adipocyte and adipocyte differentiation with and of multiple to PPARγ expression a of that the of multiple signaling and cell-based screening the of small molecules that We previously approach to the small molecule as an of PPARγ expression and that small molecule is an of Interestingly, of action the of signaling preadipocytes. profiling the of preadipocyte gene we identified the transcription factor as a of action of is a small of peroxisome proliferator-activated expression and adipocyte We adipogenic small molecules an to identify with of action distinct from that of and PPARγ the of the small molecule phenamil as a of adipocyte differentiation. Interestingly, phenamil PPARγ expression a distinct from harmine. To the of phenamil we performed transcriptional profiling of 3T3-F442A and identified variant as a expression of promotes PPARγ expression and differentiation and to of PPARγ the differentiation identify as a of adipocyte differentiation that is to small molecule and was from was and from We and was and from and 3T3-F442A preadipocyte cell and as previously described small molecule is an of of is a small of peroxisome proliferator-activated expression and adipocyte of was performed and the cell as described of an adipocyte 3T3-L1 with and 3T3-F442A and as described of is a small of peroxisome proliferator-activated expression and adipocyte and was of was and to the was performed a was to and and and and and from and and and to expression performed the of phenamil as a small molecule of identified the amiloride derivative phenamil as an adipogenic screening a of a cell-based small molecule is an of of both 3T3-L1 and 3T3-F442A with phenamil and the adipogenic of with to both phenamil and the PPARγ the expression of the adipogenic and and PPARγ is the of adipogenesis, we as an PPARγ a receptor and a is a the adipocyte factor that phenamil was as a PPARγ the PPARγ a phenamil as a that phenamil promotes adipocyte differentiation a distinct from that of PPARγ and a of molecules as of the of of a and to a of and of the amiloride from and as the of and amiloride of receptor action a To the the adipogenic of phenamil and we amiloride to adipogenic of phenamil was amiloride expression of the of and 3T3-L1 3T3-F442A the of phenamil adipocyte gene Interestingly, to phenamil the expression of PPARγ a distinct of action with phenamil of PPARγ expression with the transcription and to PPARγ to and expression of induces and of and the transcriptional of and we as phenamil the expression of to acutely PPARγ expression is of adipogenic small molecule that we small molecule is an of promotes PPARγ expression of signaling and of expression small molecule is an of of is a small of peroxisome proliferator-activated expression and adipocyte of that the of action of phenamil is distinct from that of harmine. phenamil was to the of the and and phenamil additive adipogenic gene expression and with of action that phenamil a distinct from that of the previously identified adipogenic and is a of PPARγ expression preadipocytes. expression differentiation of 3T3-F442A with phenamil PPARγ and and PPARγ expression was acutely phenamil of and phenamil and differentiation 3T3-F442A differentiation the expression of and from 3T3-F442A phenamil and expression of transcription peroxisome proliferator-activated receptor and Phenamil the signaling Phenamil and and gene expression 3T3-F442A the of and of and Phenamil regulate signaling pathways and expression of Phenamil and an additive the expression of PPARγ and gene 3T3-F442A with phenamil both of the adipogenic we performed transcriptional profiling of 3T3-F442A with phenamil We that of phenamil action phenamil PPARγ expression We transcriptional a of including and PPARγ of phenamil of the of gene expression phenamil that and as as PPARγ expression was that and PPARγ phenamil and phenamil that of is and We that of phenamil action to amiloride that as amiloride phenamil and of rapidly phenamil 3T3-F442A preadipocytes. 3T3-F442A with phenamil of phenamil and and PPARγ gene that and PPARγ phenamil was phenamil of and and a of 3T3-F442A with phenamil and of of and phenamil as as PPARγ expression was of the phenamil and PPARγ and PPARγ and expression variant peroxisome proliferator-activated receptor of and expression phenamil was preadipocyte and was We that phenamil promotes the differentiation of a the of signaling and small molecule phenamil induces differentiation and is to and that pathways that the phenamil both and PPARγ expression and adipocyte the that phenamil to PPARγ we 3T3-L1 preadipocytes. of PPARγ expression and the of the and that of PPARγ the differentiation We adipocyte differentiation We a of a transcription of differentiation with adipogenic 3T3-L1 expression of PPARγ and and to the PPARγ expression PPARγ expression 3T3-L1 differentiation and as To the of adipocyte differentiation was cell lines, we 3T3-F442A expression adipogenic PPARγ and adipogenic cell PPARγ expression and adipocyte differentiation 3T3-L1 of induces expression of PPARγ and 3T3-L1 preadipocytes. 3T3-L1 with an expression was and gene expression was of adipocyte differentiation of 3T3-L1 preadipocytes. 3T3-L1 with the and with of PPARγ and from to of 3T3-L1 was and of 3T3-L1 variant peroxisome proliferator-activated receptor adipocyte differentiation 3T3-F442A of induces expression of PPARγ and adipocyte differentiation 3T3-F442A of 3T3-F442A 3T3-F442A with the and with of PPARγ and variant peroxisome proliferator-activated receptor the of to phenamil's effects, we both and we expression of the of phenamil to PPARγ expression and differentiation. and 3T3-L1 with phenamil the of both and phenamil the expression of PPARγ and the phenamil was that of phenamil's adipocyte differentiation the that the adipogenic that is the the of phenamil was an that phenamil was to differentiation expression was is that the of we was we the that phenamil to of we that is phenamil is with preadipocytes. We 3T3-L1 a of differentiation with adipogenic 3T3-L1 expression of PPARγ and adipocyte differentiation with the that and and that phenamil to the adipogenic of and of PPARγ that and of PPARγ to To we 3T3-F442A a We and previously to PPARγ and expression of is a small of peroxisome proliferator-activated expression and adipocyte signaling of and peroxisome proliferator-activated receptor 3T3-F442A PPARγ PPARγ expression and differentiation and and of the of including and was PPARγ both the and of phenamil that phenamil's adipogenic is PPARγ the expression of both and was of that phenamil of PPARγ of PPARγ the adipogenic of phenamil of 3T3-F442A PPARγ PPARγ expression of and is of that is of PPARγ and of of including and is PPARγ both the and of phenamil expression was variant peroxisome proliferator-activated receptor previously screening the of small molecules that regulate differentiation of small molecule is an of the we identified a and as a to identify transcriptional with the to preadipocyte was previously as an of and the a of and of the amiloride from and as the of and amiloride of receptor action a Phenamil and to gene an amiloride and of the Interestingly, that the adipogenic of amiloride that as adipogenic of amiloride 3T3-L1 3T3-F442A We phenamil previously signaling pathways adipogenesis, including the to phenamil signaling and phenamil additive adipogenic with distinct of action ETS a of transcriptional mediating and differentiation. of transcription of and an transcription transcription of the transcriptional the and and of including cell and that regulate the expression of as and an transcription of the the transcription factor to of and is adipocyte differentiation and to and a and identified as a gene and that factor PPARγ expression and the differentiation of preadipocyte cell expression of expression of expression of the differentiation of multiple preadipocyte cell of PPARγ expression the of phenamil PPARγ expression of that of PPARγ the differentiation is a factor that adipogenic gene expression and differentiation. that is a to phenamil's adipogenic effects, the of we identified including that to adipogenic of adipogenesis, that regulate expression of the expression of PPARγ and adipogenesis, that adipocyte differentiation of the of phenamil an to adipocyte differentiation and PPARγ expression to to as ligands PPARγ is a peroxisome proliferator-activated receptor and of of cell the that is the the of of the and the of use of is effects, including and of a We previously identified the small molecule as an of PPARγ expression that small molecule is an of the with that the of PPARγ expression an approach the of the we identified phenamil as a small molecule that induces PPARγ expression a distinct of the pathways that of PPARγ expression to small molecules proliferator-activated receptor γ (PPARγ) is a of the receptor that as the transcriptional of of a transcription PPARγ with receptor and adipogenic gene PPARγ a of and as and transcriptional pathways that expression of PPARγ to that to PPARγ expression and expression of induces and of transcription transcription factor is a key of adipocyte of factor transcriptional of and factor peroxisome expression and and of transcription factor a of with to and factor transcription regulate adipocyte and adipocyte differentiation with and of multiple to PPARγ expression a of that the of multiple signaling We and cell-based screening the of small molecules that We previously approach to the small molecule as an of PPARγ expression and that small molecule is an of Interestingly, of action the of signaling preadipocytes. profiling the of preadipocyte gene we identified the transcription factor as a of action of is a small of peroxisome proliferator-activated expression and adipocyte We adipogenic small molecules an to identify with of action distinct from that of and PPARγ We the of the small molecule phenamil as a of adipocyte differentiation. Interestingly, phenamil PPARγ expression a distinct from harmine. To the of phenamil we performed transcriptional profiling of 3T3-F442A and identified variant as a expression of promotes PPARγ expression and differentiation and to of PPARγ the differentiation identify as a of adipocyte differentiation that is to small molecule and was from was and from We and was and from and 3T3-F442A preadipocyte cell and as previously described small molecule is an of of is a small of peroxisome proliferator-activated expression and adipocyte of was performed and the cell as described of an adipocyte 3T3-L1 with and 3T3-F442A and as described of is a small of peroxisome proliferator-activated expression and adipocyte and was of was and to the was performed a was to and and and and and from and and and to expression performed the and was from was and from We and was and from Phenamil was from was and from We and was and from and 3T3-F442A preadipocyte cell and as previously described small molecule is an of of is a small of peroxisome proliferator-activated expression and adipocyte of was performed and the cell as described of an adipocyte 3T3-L1 with and 3T3-F442A and as described of is a small of peroxisome proliferator-activated expression and adipocyte 3T3-L1 and 3T3-F442A preadipocyte cell and as previously described small molecule is an of of is a small of peroxisome proliferator-activated expression and adipocyte of was performed and the cell as described of an adipocyte 3T3-L1 with and 3T3-F442A and as described of is a small of peroxisome proliferator-activated expression and adipocyte and was of was and to the was performed a was to and and and and and was of was and to the was performed a was to and and and and and from and and and to expression performed the from and and and to expression performed the of phenamil as a small molecule of identified the amiloride derivative phenamil as an adipogenic screening a of a cell-based small molecule is an of of both 3T3-L1 and 3T3-F442A with phenamil and the adipogenic of with to both phenamil and the PPARγ the expression of the adipogenic and and PPARγ is the of adipogenesis, we as an PPARγ a receptor and a is a the adipocyte factor that phenamil was as a PPARγ the PPARγ a phenamil as a that phenamil promotes adipocyte differentiation a distinct from that of PPARγ and a of molecules as of the of of a and to a of and of the amiloride from and as the of and amiloride of receptor action a To the the adipogenic of phenamil and we amiloride to adipogenic of phenamil was amiloride expression of the of and 3T3-L1 3T3-F442A the of phenamil adipocyte gene Interestingly, to phenamil the expression of PPARγ a distinct of action with phenamil of PPARγ expression with the transcription and to PPARγ to and expression of induces and of and the transcriptional of and we as phenamil the expression of to acutely PPARγ expression is of adipogenic small molecule that we small molecule is an of promotes PPARγ expression of signaling and of expression small molecule is an of of is a small of peroxisome proliferator-activated expression and adipocyte of that the of action of phenamil is distinct from that of harmine. phenamil was to the of the and and phenamil additive adipogenic gene expression and with of action that phenamil a distinct from that of the previously identified adipogenic and and Phenamil the signaling Phenamil and and gene expression 3T3-F442A the of and of and Phenamil regulate signaling pathways and expression of Phenamil and an additive the expression of PPARγ and gene 3T3-F442A with phenamil both of the adipogenic we performed transcriptional profiling of 3T3-F442A with phenamil We that of phenamil action phenamil PPARγ expression We transcriptional a of including and PPARγ of phenamil of the of gene expression phenamil that and as as PPARγ expression was that and PPARγ phenamil and phenamil that of is and We that of phenamil action to amiloride that as amiloride phenamil and of rapidly phenamil 3T3-F442A preadipocytes. 3T3-F442A with phenamil of phenamil and and PPARγ gene that and PPARγ phenamil was phenamil of and and a of 3T3-F442A with phenamil and of of and phenamil as as PPARγ expression was of the phenamil and PPARγ and PPARγ and expression variant peroxisome proliferator-activated receptor of and expression phenamil was preadipocyte and was We that phenamil promotes the differentiation of a the of signaling and small molecule phenamil induces differentiation and is to and that pathways that the phenamil both and PPARγ expression and adipocyte the that phenamil to PPARγ we 3T3-L1 preadipocytes. of PPARγ expression and the of the and that of PPARγ the differentiation We adipocyte differentiation We a of a transcription of differentiation with adipogenic 3T3-L1 expression of PPARγ and and to the PPARγ expression PPARγ expression 3T3-L1 differentiation and as To the of adipocyte differentiation was cell lines, we 3T3-F442A expression adipogenic PPARγ and adipogenic cell PPARγ expression and adipocyte differentiation 3T3-L1 of induces expression of PPARγ and 3T3-L1 preadipocytes. 3T3-L1 with an expression was and gene expression was of adipocyte differentiation of 3T3-L1 preadipocytes. 3T3-L1 with the and with of PPARγ and from to of 3T3-L1 was and of 3T3-L1 variant peroxisome proliferator-activated receptor adipocyte differentiation 3T3-F442A of induces expression of PPARγ and adipocyte differentiation 3T3-F442A of 3T3-F442A 3T3-F442A with the and with of PPARγ and variant peroxisome proliferator-activated receptor the of to phenamil's effects, we both and we expression of the of phenamil to PPARγ expression and differentiation. and 3T3-L1 with phenamil the of both and phenamil the expression of PPARγ and the phenamil was that of phenamil's adipocyte differentiation the that the adipogenic that is the the of phenamil was an that phenamil was to differentiation expression was is that the of we was we the that phenamil to of we that is phenamil is with preadipocytes. We 3T3-L1 a of differentiation with adipogenic 3T3-L1 expression of PPARγ and adipocyte differentiation with the that and and that phenamil to the adipogenic of and of PPARγ that and of PPARγ to To we 3T3-F442A a We and previously to PPARγ and expression of is a small of peroxisome proliferator-activated expression and adipocyte signaling of and peroxisome proliferator-activated receptor 3T3-F442A PPARγ PPARγ expression and differentiation and and of the of including and was PPARγ both the and of phenamil that phenamil's adipogenic is PPARγ the expression of both and was of that phenamil of PPARγ of PPARγ the adipogenic of phenamil of 3T3-F442A PPARγ PPARγ expression of and is of that is of PPARγ and of of including and is PPARγ both the and of phenamil expression was variant peroxisome proliferator-activated receptor of phenamil as a small molecule of identified the amiloride derivative phenamil as an adipogenic screening a of a cell-based small molecule is an of of both 3T3-L1 and 3T3-F442A with phenamil and the adipogenic of with to both phenamil and the PPARγ the expression of the adipogenic and and PPARγ is the of adipogenesis, we as an PPARγ a receptor and a is a the adipocyte factor that phenamil was as a PPARγ the PPARγ a phenamil as a that phenamil promotes adipocyte differentiation a distinct from that of PPARγ and a of molecules as of the of of a and to a of and of the amiloride from and as the of and amiloride of receptor action a To the the adipogenic of phenamil and we amiloride to adipogenic of phenamil was amiloride expression of the of and 3T3-L1 3T3-F442A the of phenamil adipocyte gene Interestingly, to phenamil the expression of PPARγ a distinct of action with phenamil of PPARγ expression with the transcription and to PPARγ to and expression of induces and of and the transcriptional of and we as phenamil the expression of to acutely PPARγ expression is of adipogenic small molecule that we small molecule is an of promotes PPARγ expression of signaling and of expression small molecule is an of of is a small of peroxisome proliferator-activated expression and adipocyte of that the of action of phenamil is distinct from that of harmine. phenamil was to the of the and and phenamil additive adipogenic gene expression and with of action that phenamil a distinct from that of the previously identified adipogenic and We identified the amiloride derivative phenamil as an adipogenic screening a of a cell-based small molecule is an of of both 3T3-L1 and 3T3-F442A with phenamil and the adipogenic of with to both phenamil and the PPARγ the expression of the adipogenic and and PPARγ is the of adipogenesis, we as an PPARγ a receptor and a is a the adipocyte factor that phenamil was as a PPARγ the PPARγ a phenamil as a that phenamil promotes adipocyte differentiation a distinct from that of PPARγ and a of molecules as of the of of a and to a of and of the amiloride from and as the of and amiloride of receptor action a To the the adipogenic of phenamil and we amiloride to adipogenic of phenamil was amiloride expression of the of and 3T3-L1 3T3-F442A We the of phenamil adipocyte gene Interestingly, to phenamil the expression of PPARγ a distinct of action with phenamil of PPARγ expression with the transcription and to PPARγ to and expression of induces and of and the transcriptional of and we as phenamil the expression of to acutely PPARγ expression is of adipogenic small molecule that we small molecule is an of promotes PPARγ expression of signaling and of expression small molecule is an of of is a small of peroxisome proliferator-activated expression and adipocyte of that the of action of phenamil is distinct from that of harmine. phenamil was to the of the and and phenamil additive adipogenic gene expression and with of action that phenamil a distinct from that of the previously identified adipogenic and of the adipogenic we performed transcriptional profiling of 3T3-F442A with phenamil We that of phenamil action phenamil PPARγ expression We transcriptional a of including and PPARγ of phenamil of the of gene expression phenamil that and as as PPARγ expression was that and PPARγ phenamil and phenamil that of is and We that of phenamil action to amiloride that as amiloride phenamil and of and expression phenamil was preadipocyte and was We that phenamil promotes the differentiation of a the of signaling and small molecule phenamil induces differentiation and is to and that pathways that the phenamil both and preadipocytes. To the adipogenic we performed transcriptional profiling of 3T3-F442A with phenamil We that of phenamil action phenamil PPARγ expression We transcriptional a of including and PPARγ of phenamil of the of gene expression phenamil that and as as PPARγ expression was that and PPARγ phenamil and phenamil that of is and We that of phenamil action to amiloride that as amiloride phenamil and of and expression phenamil was preadipocyte and was We that phenamil promotes the differentiation of a the of signaling and small molecule phenamil induces differentiation and is to and that pathways that the phenamil both and preadipocytes. PPARγ expression and adipocyte the that phenamil to PPARγ we 3T3-L1 preadipocytes. of PPARγ expression and the of the and that of PPARγ the differentiation We adipocyte differentiation We a of a transcription of differentiation with adipogenic 3T3-L1 expression of PPARγ and and to the PPARγ expression PPARγ expression 3T3-L1 differentiation and as To the of adipocyte differentiation was cell lines, we 3T3-F442A expression adipogenic PPARγ and adipogenic cell adipocyte differentiation 3T3-F442A of induces expression of PPARγ and adipocyte differentiation 3T3-F442A of 3T3-F442A 3T3-F442A with the and with of PPARγ and variant peroxisome proliferator-activated receptor the of to phenamil's effects, we both and we expression of the of phenamil to PPARγ expression and differentiation. and 3T3-L1 with phenamil the of both and phenamil the expression of PPARγ and the phenamil was that of phenamil's adipocyte differentiation the that the adipogenic that is the the of phenamil was an that phenamil was to differentiation expression was is that the of we was we the that phenamil to of we that is phenamil is with preadipocytes. We 3T3-L1 a of differentiation with adipogenic 3T3-L1 expression of PPARγ and adipocyte differentiation with the that and and that phenamil to the adipogenic of compound. To the that phenamil to PPARγ we 3T3-L1 preadipocytes. of PPARγ expression and the of the and that of PPARγ the differentiation We adipocyte differentiation We a of a transcription of differentiation with adipogenic 3T3-L1 expression of PPARγ and and to the PPARγ expression PPARγ expression 3T3-L1 differentiation and as To the of adipocyte differentiation was cell lines, we 3T3-F442A expression adipogenic PPARγ and adipogenic cell To the of to phenamil's effects, we both and we expression of the of phenamil to PPARγ expression and differentiation. and 3T3-L1 with phenamil the of both and phenamil the expression of PPARγ and the phenamil was that of phenamil's adipocyte differentiation the that the adipogenic that is the We the of phenamil was an that phenamil was to differentiation expression was is that the of we was we the that phenamil to of we that is phenamil is with preadipocytes. We 3T3-L1 a of differentiation with adipogenic 3T3-L1 expression of PPARγ and adipocyte differentiation with the that and and that phenamil to the adipogenic of compound. and of PPARγ that and of PPARγ to To we 3T3-F442A a We and previously to PPARγ and expression of is a small of peroxisome proliferator-activated expression and adipocyte signaling of and peroxisome proliferator-activated receptor 3T3-F442A PPARγ PPARγ expression and differentiation and and of the of including and was PPARγ both the and of phenamil that phenamil's adipogenic is PPARγ the expression of both and was of that phenamil of PPARγ that and of PPARγ to To we 3T3-F442A a We and previously to PPARγ and expression of is a small of peroxisome proliferator-activated expression and adipocyte signaling of and peroxisome proliferator-activated receptor 3T3-F442A PPARγ PPARγ expression and differentiation and and of the of including and was PPARγ both the and of phenamil that phenamil's adipogenic is PPARγ the expression of both and was of that phenamil of PPARγ previously screening the of small molecules that regulate differentiation of small molecule is an of the we identified a and as a to identify transcriptional with the to preadipocyte was previously as an of and the a of and of the amiloride from and as the of and amiloride of receptor action a Phenamil and to gene an amiloride and of the Interestingly, that the adipogenic of amiloride that as adipogenic of amiloride 3T3-L1 3T3-F442A We phenamil previously signaling pathways adipogenesis, including the to phenamil signaling and phenamil additive adipogenic with distinct of action ETS a of transcriptional mediating and differentiation. of transcription of and an transcription transcription of the transcriptional the and and of including cell and that regulate the expression of as and an transcription of the the transcription factor to of and is adipocyte differentiation and to and a and identified as a gene and that factor PPARγ expression and the differentiation of preadipocyte cell expression of expression of expression of the differentiation of multiple preadipocyte cell of PPARγ expression the of phenamil PPARγ expression of that of PPARγ the differentiation is a factor that adipogenic gene expression and differentiation. that is a to phenamil's adipogenic effects, the of we identified including that to adipogenic of adipogenesis, that regulate expression of the expression of PPARγ and adipogenesis, that adipocyte differentiation of the of phenamil an to adipocyte differentiation and PPARγ expression to to as ligands PPARγ is a peroxisome proliferator-activated receptor and of of cell the that is the the of of the and the of use of is effects, including and of a We previously identified the small molecule as an of PPARγ expression that small molecule is an of the with that the of PPARγ expression an approach the of the we identified phenamil as a small molecule that induces PPARγ expression a distinct of the pathways that of PPARγ expression to small molecules We previously screening the of small molecules that regulate differentiation of small molecule is an of the we identified a and as a to identify transcriptional with the to preadipocyte differentiation. Phenamil was previously as an of and the a of and of the amiloride from and as the of and amiloride of receptor action a Phenamil and to gene an amiloride and of the Interestingly, that the adipogenic of amiloride that as adipogenic of amiloride 3T3-L1 3T3-F442A We phenamil previously signaling pathways adipogenesis, including the to phenamil signaling and phenamil additive adipogenic with distinct of action ETS a of transcriptional mediating and differentiation. of transcription of and an transcription transcription of the transcriptional the and and of including cell and that regulate the expression of as and an transcription of the the transcription factor to of and is adipocyte differentiation and to and a and We identified as a gene and that factor PPARγ expression and the differentiation of preadipocyte cell expression of expression of expression of the differentiation of multiple preadipocyte cell of PPARγ expression the of phenamil PPARγ expression of that of PPARγ the differentiation is a factor that adipogenic gene expression and differentiation. that is a to phenamil's adipogenic effects, the of we identified including that to adipogenic of adipogenesis, that regulate expression of the expression of PPARγ and adipogenesis, that adipocyte differentiation of the of phenamil an to adipocyte differentiation and PPARγ expression to to as ligands PPARγ is a peroxisome proliferator-activated receptor and of of cell the that is the the of of the and the of use of is effects, including and of a We previously identified the small molecule as an of PPARγ expression that small molecule is an of the with that the of PPARγ expression an approach the of the we identified phenamil as a small molecule that induces PPARγ expression a distinct of the pathways that of PPARγ expression to small molecules and with with ETS variant peroxisome proliferator-activated receptor γ receptor

References

23